Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 800 of 1294 entries
View as:

Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01242826 Org: User:
Start: 02/28/11 End: 03/31/11 Due: 03/31/12

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)

Phase: N/A Priority: Normal
NCT ID: NCT04083820 Org: User:
Start: 09/16/19 End: 09/27/21 Due: 09/27/22

A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage

Phase: N/A Priority: Normal
NCT ID: NCT03987451 Org: User:
Start: 06/18/19 End: 06/10/21 Due: 06/10/22

Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT01698944 Org: User:
Start: 05/16/01 End: 11/18/02 Due: 11/18/03

Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT00703911 Org: User:
Start: 03/31/08 End: 07/31/10 Due: 07/31/11

Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc

Phase: N/A Priority: Normal
NCT ID: NCT04189848 Org: User:
Start: 12/03/19 End: 02/27/20 Due: 02/27/21

Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01009580 Org: User:
Start: 11/05/09 End: 08/23/10 Due: 08/23/11

Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT03552757 Org: User:
Start: 06/04/18 End: 05/01/20 Due: 05/01/21

Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00617253 Org: User:
Start: 07/12/07 End: 06/30/08 Due: 06/30/09

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT03751657 Org: User:
Start: 11/29/18 End: 01/17/20 Due: 01/17/21

Factor VIIa in Acute Intracerebral Haemorrhage

Phase: N/A Priority: Normal
NCT ID: NCT00266006 Org: User:
Start: 01/31/06 End: 04/30/07 Due: 04/30/08

NovoLet® Surveillance Study on Using Human Insulin System in Indonesia

Phase: N/A Priority: Normal
NCT ID: NCT01492153 Org: User:
Start: 02/11/03 End: 09/05/06 Due: 09/05/07

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Sweden, as Part of Local Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04601753 Org: User:
Start: 11/12/20 End: 02/02/23 Due: 02/02/24

A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00978393 Org: User:
Start: 09/16/09 End: 06/08/11 Due: 06/08/12

Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00399711 Org: User:
Start: 11/30/06 End: 11/30/07 Due: 11/30/08

Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT02941354 Org: User:
Start: 10/10/16 End: 06/20/17 Due: 06/20/18

Observational Study of NovoNorm® in Subjects With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01498913 Org: User:
Start: 08/30/01 End: 03/25/05 Due: 03/25/06

Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone

Phase: N/A Priority: Normal
NCT ID: NCT01215435 Org: User:
Start: 03/31/11 End: 09/30/12 Due: 09/30/13

Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00312104 Org: User:
Start: 04/30/02 End: 03/31/03 Due: 03/31/04

Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral Haemorrhage

Phase: N/A Priority: Normal
NCT ID: NCT01566786 Org: User:
Start: 08/31/01 End: 10/31/02 Due: 10/31/03

A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02207374 Org: User:
Start: 08/04/14 End: 02/27/16 Due: 02/27/17

Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00806858 Org: User:
Start: 11/30/08 End: 07/31/09 Due: 07/31/10

Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01620333 Org: User:
Start: 02/29/00 End: 04/30/00 Due: 04/30/01

A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT01365520 Org: User:
Start: 06/30/11 End: 09/30/11 Due: 09/30/12

Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01487304 Org: User:
Start: 04/30/05 End: 06/30/06 Due: 06/30/07